Correction: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma, (Aging (Albany NY), (2022), 14(11), (4673–4698), (10.18632/aging.203241))

Dan Zi, Qing Li, Cheng xiong Xu, Zhi Wei Zhou, Guan Bin Song, Cheng Bin Hu, Fang Wen, Han Lin Yang, Lei Nie, Xing Zhao, Jun Tan, Shu Feng Zhou, Zhi Xu He

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Correction: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma, (Aging (Albany NY), (2022), 14(11), (4673–4698), (10.18632/aging.203241))'. Together they form a unique fingerprint.

Medicine & Life Sciences